Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells

American Journal of Pathology

Volumn 162, Issue 5, 2003, Pages 1503-1513

  Darmoul, Dalila ^a   Gratio, Valérie ^b   Devaud, Hélène ^b   Lehy, Thérèse ^b   Laburthe, Marc ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037406817     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64283-6     Document Type: Article

References (54)

1. Chung DC; The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000, 119:854-865
2. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170
3. Favoni RE, de Cupis A: The role of Polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach Pharmacol Rev 2000, 52:179-206
4. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161-195
5. McCawley LJ, Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000, 6:149-156
6. Dery O, Corvera CU, Steinhoff M, Bunnett NW: Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998, 274:C1429-C1452
7. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R: Proteinase-activated receptors. Pharmacol Rev 2001, 53:245-282
8. Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991, 64:1057-1068
9. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997, 386:502-506
10. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998, 95:6642-6646
11. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J: Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994, 91:9208-9212
12. Hollenberg MD, Compton SJ: International Union of Pharmacology. XX-VIII proteinase-activated receptors. Pharmacol Rev 2002, 54:203-217
13. Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M: Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 2001, 85:772-779
14. Iversen LH, Okholm M, Thorlacius-Ussing O: Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - a preliminary study. Thromb Haemost 1996, 76:523-528
15. Modrau II, Iversen LL, Thorlacius-Ussing OO: Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery. Thromb Res 2001, 104:309-315
16. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RC: Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor Lancet 1995, 346:1004-1005
17. Garcia-Avello A, Galindo-Alvarez J, Martinez-Molina E, Cesar-Perez J, Navarro JL: Coagulative system activation and fibrinolytic system inhibition activities arise from tumoral draining vein in colon carcinoma. Thromb Res 2001, 104:421-425
18. Pearlstein E, Ambrogio C, Gasic G, Karpatkin S: Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1, pentanediyl)amide. Cancer Res 1981, 41:4535-4539
19. Chiang HS, Swaim MW, Huang TF: Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br J Haematol 1994, 87:325-331
20. Augeron C, Laboisse CL: Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984, 44:3961-3969
21. Fantini J, Abadie B, Tirard A, Remy L, Ripert JP, el Battari A, Marvaldi J: Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J Cell Sci 1986, 83:235-249
22. Zweibaum A, Laburthe M, Grasset E, Louvard D: The gastrointestinal system: intestinal absorption and secretion. Handbook of Physiology. Edited by M Field, RA Frizzell. Bethesda, American Physiological Society, 1991, pp 223-255
23. Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallee D, Blais A, Darmoul D, Laburthe M: Characterization of a common VIP-PACAP receptor in human small intestinal epithelium Am J Physiol 1993, 264:E294-E300
24. Burk RR: A factor from a transformed cell line that affects cell migration. Proc Natl Acad Sci USA 1973, 70:369-372
25. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF: Internalization and recycling of activated thrombin receptors. J Biol Chem 1993, 208:13756-13763
26. Wojtukiewicz MZ, Tang DG, Ben-Josef E, Renaud C, Walz DA, Honn KV: Solid tumor cells express functional "tethered ligand" thrombin receptor Cancer Res 1995, 55:698-704
27. Kawabata A, Saifeddine M, Al-Ani B, Leblond L, Hollenberg MD: Evaluation of proteinase-activated receptor-1 (PAR1 ) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. J Pharmacol Exp Ther 1999, 288:358-370
28. Liu LW, Vu TK, Esmon CT, Coughlin SR: The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 1991, 266:16977-16980
29. Schmidt VA, Vitale E, Bahou WF: Genomic cloning and characterization of the human thrombin receptor gene. Structural similarity to the proteinase activated receptor-2 gene. J Biol Chem 1996, 271:9307-9312
30. Schramek H: MAP kinases: from intracellular signals to physiology and disease. News Physiol Sci 2002, 17:62-67
31. Andre F, Rigot V, Remacle-Bonnet M, Luis J, Pommier G, Marvaldi J: Protein kinases C-gamma and -delta are involved in insulin-like growth factor I-induced migration of colonic epithelial cells. Gastroenterology 1999, 116:64-77
32. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R: Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998, 4:909-914
33. Rudroff C, Seibold S, Kaufmann R, Zetina CC, Reise K, Schafer U, Schneider A, Brockmann M, Scheele J, Neugebauer EA: Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro. Clin Exp Metastasis 2002, 19:181-189
34. Kaufmann R, Schafberg H, Rudroff C, Nowak G: Thrombin receptor activation results in calcium signaling and protein kinase C-dependent stimulation of DNA synthesis in HEp-2g laryngeal carcinoma cells. Cancer 1997, 80:2068-2074
35. Kaufmann R, Junker U, Junker K, Nuske K, Ranke C, Zieger M, Scheele J: The serine proteinase thrombin promotes migration of human renal carcinoma cells by a PKA-dependent mechanism. Cancer Lett 2002, 180:183-190
36. D'Andrea MR, Derian CK, Santulli RJ, Andrade-Gordon P: Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues Am J Pathol 2001, 158:2031-2041
37. Liu Y, Gilcrease MZ, Henderson Y, Yuan XH, Clayman GL, Chen Z: Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett 2001, 169:173-180
38. Martin CB, Mahon GM, Klinger MB, Kay RJ, Symons M, Der CJ, Whitehead IP: The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 2001, 20:1953-1963
39. Hollenberg MD, Saifeddine M, al-Ani B, Kawabata A: Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 1997, 75:832-841
40. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese Jr RV, Tam C, Coughlin SR: A dual thrombin receptor system for platelet activation. Nature 1998, 394:690-694
41. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR: PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000, 404:609-613
42. Mendelsohn J: The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer 2001, 8:3-9
43. Giovannucci E: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001, 131:3109S-3120S
44. Dignass AU, Lynch-Devaney K, Podolsky DK: Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 1994, 202:701-709
45. Maoret JJ, Anini Y, Rouyer-Fessard C, Gully D, Laburthe M: Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer 1999, 80:448-454
46. Stepan VM, Sawada M, Todisco A, Dickinson CJ: Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells Mol Med 1999, 5:147-159
47. Walz DA, Fenton JW: The role of thrombin in tumor cell metastasis. Invasion Metastasis 1994, 14:303-308
48. Nierodzik ML, Kajumo F, Karpatkin S: Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 1992, 52:3267-3272
49. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, Mammen EF, Honn KV: Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993, 54:793-806
50. Chiang HS, Yang RS, Huang TF: Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin. Br J Cancer 1996, 73:902-908
51. Rickles FR, Falanga A: Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001, 102:V215-V224
52. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK: Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 1996, 93:14765-14770
53. Saclarides TJ: Angiogenesis in colorectal cancer. Surg Clin North Am 1997, 77:253-260
54. Zacharski LR, Memoli VA, Morain WD, Schlaeppi JM, Rousseau SM: Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 1995, 73:793-797